Get started
BioNTech SEBioNTech SEBioNTech SE

BioNTech SE

No trades
OverviewFinancialsNewsDocumentsCommunityTechnicalsForecastsSeasonalsOptionsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪26.53 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.63 USD
Net income (FY)
‪−719.65 M‬ USD
Revenue (FY)
‪2.98 B‬ USD
Shares float
‪238.79 M‬
Beta (1Y)
0.95

About BioNTech SE


Sector
Health Technology
Industry
Biotechnology
CEO
Ugur Sahin
Website
biontech.de
Headquarters
Mainz
Founded
2008
IPO date
Oct 10, 2019
Identifiers
3
ISIN US09075V1026
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Check out other big names from the same industry as BNTX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


FBT
First Trust Amex Biotech Index Fund
Weight
3.70%
Market value
‪88.76 M‬
USD
IBB
iShares Biotechnology ETF
Weight
0.65%
Market value
‪52.89 M‬
USD
FNDF
Schwab Fundamental International Equity ETF
Weight
0.11%
Market value
‪23.04 M‬
USD
TCAF
T. Rowe Price Capital Appreciation Equity ETF
Weight
0.33%
Market value
‪20.63 M‬
USD
SPDW
State Street SPDR Portfolio Developed World ex-US ETF
Weight
0.03%
Market value
‪10.41 M‬
USD
BTEE
iShares NASDAQ US Biotechnology UCITS ETF
Weight
0.83%
Market value
‪8.13 M‬
USD
BTEC
iShares NASDAQ US Biotechnology UCITS ETF
Weight
0.83%
Market value
‪8.13 M‬
USD
BBH
VanEck Biotech ETF
Weight
2.02%
Market value
‪7.94 M‬
USD
BBEU
JPMorgan BetaBuilders Europe ETF
Weight
0.08%
Market value
‪7.28 M‬
USD
IDNA
iShares Genomics Immunology and Healthcare ETF
Weight
4.13%
Market value
‪5.97 M‬
USD
QQQJ
Invesco NASDAQ Next Gen 100 ETF
Weight
0.53%
Market value
‪4.79 M‬
USD

Explore more ETFs